Breaking the Hypoxia Barrier: Supramolecular Nanoassemblies Empower Photodynamic Therapy of Tumors
Angewandte Chemie International Edition · 22.06.2026 · 65 (26)
DOI: 10.1002/anie.202525238 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 01.05.2026. Verfasst von Yuxiao Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Photosensitizing Agents, Tumor Hypoxia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 204 Literaturangaben. Gefördert von: National University of Singapore, the Singapore Ministry of Education, and a start-up fund from Shandong Cancer Hospital.
Abstract (Originalsprache)
Supramolecular chemistry provides an efficient and transformative strategy for the modular integration of diverse active pharmaceutical ingredients (APIs) into nanoassemblies through weak, reversible noncovalent interactions, combining the native features of the original molecules with additional functionalities derived from supramolecular structures. Thanks to ultra‐high photosensitizer or API loading, on‐demand delivery, facile multifunction integration, scalability, and potentially simplified regulatory pathways, supramolecular nanoassemblies markedly enhance the clinical translatability of nanomedicine. In particular, rational design of these systems can overcome hypoxia barriers, revitalizing photodynamic therapy (PDT) against tumors. Despite clinical approval of PDT for cancer therapy over four decades ago, it has yet to achieve widespread adoption as a first‐line modality, largely due to the technological bottleneck of tumor hypoxia. In this review, we systematically summarize recent advances in supramolecular nanoassemblies for hypoxic tumor PDT, categorizing them into four key design principles: enriching intratumoral oxygen levels, minimizing oxygen dependence, leveraging tumor hypoxia, and enabling PDT‐involved synergistic therapies. We also discuss the intrinsic properties, advantages, and building motifs of supramolecular nanoassemblies. Finally, we highlight current challenges and future perspectives, aiming to broaden the research landscape and accelerate clinical and commercial translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Center for Nuclear Medicine and Molecular Imaging (CNMMI), Shandong Cancer Hospital and Institute, Jinan, China.
ORCID-Profile: Fang Fang, Xiaoyuan Chen
Förderung
- National University of Singapore
- the Singapore Ministry of Education
- and a start-up fund from Shandong Cancer Hospital
Zitieren
APA
Peng, Y., Shi, C., Cao, Y., Shi, L., Fang, F., & Chen, X. (2026). Breaking the Hypoxia Barrier: Supramolecular Nanoassemblies Empower Photodynamic Therapy of Tumors. Angewandte Chemie International Edition, 65(26). https://doi.org/10.1002/anie.202525238
Vancouver
Peng Y, Shi C, Cao Y, Shi L, Fang F, Chen X. Breaking the Hypoxia Barrier: Supramolecular Nanoassemblies Empower Photodynamic Therapy of Tumors. Angewandte Chemie International Edition. 2026;65(26). doi:10.1002/anie.202525238
BibTeX
@article{Peng2026,
author = {Peng, Yuxiao and Shi, Changrong and Cao, Yinghao and Shi, Linrong and Fang, Fang and Chen, Xiaoyuan},
title = {Breaking the Hypoxia Barrier: Supramolecular Nanoassemblies Empower Photodynamic Therapy of Tumors},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {26},
doi = {10.1002/anie.202525238}
}
EUVIMED